About Jiangsu Aosaikang Pharmaceutical Company

The issuer's predecessor, Jiang Ao Co., Ltd. was jointly established by domestic shareholders Yangzhou Aosaikang Pharmaceutical Co., Ltd., Nanjing Aosaikang Pharmaceutical Technology Co., Ltd. (renamed “Nanjing Aosaikang Pharmaceutical Group Co., Ltd.” on September 15, 2005, and “Nanjing Osecon Investment Management Co., Ltd.” on May 29, 2012) and foreign shareholder Kening James. The registered capital at the time of establishment was 5 million US dollars, of which Yangzhou Osecon invested 2.5 million US dollars, accounting for 50% of the registered capital, Kening James invested 1.5 million US dollars, accounting for 30% of the registered capital, and Nanjing Osecon invested 1 million US dollars, accounting for 20% of the registered capital. On July 22, 2011, the joint stock company obtained a joint stock company business license issued by the Nanjing Administration for Industry and Commerce. The registration number is 320100400019100, and the registered capital is RMB 21 million.